In-office Therapies for Men with Erectile Dysfunction

madman · Mar 7, 2024

In-office Therapies for Men with Erectile Dysfunction

Jesse N. Mills, MD, discusses the effectiveness of a selection of experimental in-office therapies for erectile dysfunction treatment.

grandroundsinurology.com

Summary:

Jesse N. Mills, MD, discusses the effectiveness of a selection of experimental in-office therapies for erectile dysfunction treatment. Throughout his presentation, Dr. Mills explores the outlook, benefits, and challenges of experimental therapy options currently pushed by external market forces, including:

Low-intensity Shockwave Therapy (LiSWT)
Platelet-Rich Plasma (PRP)
Stem Cell Therapy
Intracavernosal Injection (ICI)
Hyperbaric Oxygen

Dr. Mills concludes by stressing that although these therapy options are still considered experimental, urologists should strive to observe these therapies and hold balanced conversations with patients regarding their efficacy. He encourages urologists to stay optimistic about erectile dysfunction treatment as stewards of male health, suggesting they watch for new data in the world of experimental treatments.

madman · Mar 7, 2024

madman · Mar 7, 2024

madman · Mar 7, 2024

madman · Mar 7, 2024

* Until these studies are done, restorative therapies should be reserved for clinical trials and not offered in routine clinical practice

madman · Mar 7, 2024

madman · Mar 7, 2024

Radial Shockwave Therapy (RST)

* Still available, energy generated appears to be insufficient to stimulate much endothelial activity, enough said!

Low-intensity Shockwave Therapy (LiSWT)

* Gold standard

* Approved as first-line therapy in Europe

* Not FDA approved but FDA cleared, therefore no insurance code yet.

* CPT has been presented to AMA, we'll see.

madman · Mar 7, 2024

madman · Mar 7, 2024

madman · Mar 7, 2024

madman · Mar 7, 2024

madman · Mar 7, 2024

madman · Mar 7, 2024

Princeton IV consensus guidelines: PDE5 inhibitors and cardiac health

Been waiting on this one. Damn, that is deep! Abstract Background In 1999, 1 year after the approval of the first oral phosphodiesterase type 5 (PDE5) inhibitor for the treatment of erectile dysfunction(ED), the first Princeton Consensus Conference was held to address the clinical...

www.excelmale.com

Update on PDE-5 Inhibitors: Safety, New PDE-5 Inhibitors, Over-the-Counter PDE-5 Inhibitors?

"Princeton 4: PDE5 Inhibitors and Cardiac Health Symposium.” Selected lectures that examine the intersection between sexual health and cardiovascular health, with a focus on the pharmacologic therapy for erectile dysfunction (ED). Lectures from US experts on the newest data on safety and...

www.excelmale.com

post #2

Sildenafil, 25 Years Later

Sildenafil: 25 Years Later – Summary Twenty-five years ago, the FDA’s approval of sildenafil (Viagra) radically reshaped the treatment of erectile dysfunction. Editor-in-Chief of Grand Rounds in Urology, E. David Crawford, MD, sits down to discuss the history and future of PDE5 inhibitors with...

www.excelmale.com

madman · Mar 7, 2024

Intracavernosal injection therapy in erectile dysfunction

Current status of intracavernosal injection therapy in erectile dysfunction (2023) Bobo W. Elena, Melchiode Zachary, Pavaluri Haritha, Bobo A. Graham & Hellstrom J.G. Wayne Abstract Introduction Erectile dysfunction (ED) is defined as the inability to attain and/or maintain a penile...

www.excelmale.com

Injection Therapy for Erectile Dysfunction Explained

In this webinar, Dr. Martin Gross, Urologist, reviews dosing, proper injection technique, and safety, and answers all of your questions about Injection Therapy for erectile dysfunction. In this webinar, Dr. Gross discusses: - Injection Medication - Syringe and Dosing - Injection Techniques -...

www.excelmale.com